Annual International Primary CNS Lymphoma Collaborative Group Meeting
年度国际原发性中枢神经系统淋巴瘤合作小组会议
基本信息
- 批准号:8651990
- 负责人:
- 金额:$ 0.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-09-01 至 2014-08-31
- 项目状态:已结题
- 来源:
- 关键词:American Society of HematologyCentral Nervous System LymphomaClassificationCollaborationsCountryDataDatabasesDiagnosisDiagnosticDisciplineDiseaseDisease OutcomeEnvironmentExtranodalGroup MeetingsHIVHealthHumanHuman Herpesvirus 4ImageImmuneImmunocompromised HostIncidenceInternationalLouisianaLymphomaMalignant neoplasm of brainNervous system structureNon-Hodgkin&aposs LymphomaOrgan TransplantationPathogenesisPatientsPeer ReviewPublishingResearchReview LiteratureRoleSpecialistStagingTherapeuticToxic effectTreatment ProtocolsVariantfollow-upmeetingspublic health relevancesymposium
项目摘要
Project Summary
Primary central nervous system lymphoma (PCNSL) is an extranodal variant of non-
Hodgkin lymphoma (NHL) that is confined to the nervous system. The diagnostic and
therapeutic approaches to PCNSL are different from those that are applied to other
forms of NHL or to other brain cancers. The International Primary Central Nervous
System Lymphoma Collaborative Group (IPCG) consists of specialists from multiple
countries and disciplines dedicated to the study of PCNSL. The IPCG holds an annual
scientific conference at the American Society of Hematology meeting in which various
research topics related to PCNSL are discussed. An international expert on the topic
under discussion is selected each year by an executive committee to chair the scientific
conference. These meetings have led to multiple collaborative projects that have
impacted the field and that have been published in the peer-reviewed literature. The
annual IPCG meeting is a critical forum for generating new ideas and approaches to this
unique form of brain cancer. The 2013 conference topic is PCNSL in the
Immunocompromised Human Host.
项目摘要
原发性中枢神经系统淋巴瘤(PCNSL)是一种非淋巴结转移性淋巴瘤,
霍奇金淋巴瘤(NHL),局限于神经系统。诊断和
PCNSL的治疗方法与应用于其他疾病的治疗方法不同。
非霍奇金淋巴瘤或其他脑癌。国际初级中枢神经
系统淋巴瘤协作组(IPCG)由来自多个国家的专家组成
致力于PCNSL研究的国家和学科。IPCG每年举行一次
在美国血液学学会的科学会议上,
讨论了与PCNSL相关的研究课题。该专题的国际专家
每年由一个执行委员会选出,
会议这些会议促成了多个合作项目,
影响了该领域,并已在同行评审文献中发表。的
年度IPCG会议是一个重要的论坛,可以产生新的想法和方法,
一种独特的脑癌2013年会议的主题是PCNSL在
免疫功能低下的人类宿主。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Tracy T Batchelor其他文献
Correcting the drug development paradigm for glioblastoma requires serial tissue sampling
纠正胶质母细胞瘤的药物开发范式需要连续组织采样
- DOI:
- 发表时间:
2023 - 期刊:
- 影响因子:0
- 作者:
Kirit Singh;K. Hotchkiss;I. Parney;J. D. de Groot;S. Sahebjam;N. Sanai;M. Plattén;E. Galanis;Michael Lim;P. Wen;G. Minniti;H. Colman;T. Cloughesy;M. Mehta;M. Geurts;I. Arrillaga;A. Desjardins;K. Tanner;S. Short;David F. Arons;Elizabeth S Duke;W. Wick;S. Bagley;D. Ashley;P. Kumthekar;R. Verhaak;A. Chalmers;Anoop P. Patel;Colin Watts;P. Fecci;Tracy T Batchelor;M. Weller;M. Vogelbaum;M. Preusser;Mitchel S. Berger;M. Khasraw - 通讯作者:
M. Khasraw
Association of MTHFR Polymorphisms With Leukoencephalopathy Risk in Patients With Primary CNS Lymphoma Treated With Methotrexate-Based Regimens
MTHFR 多态性与接受甲氨蝶呤方案治疗的原发性中枢神经系统淋巴瘤患者白质脑病风险的关联
- DOI:
10.1212/wnl.0000000000207670 - 发表时间:
2023 - 期刊:
- 影响因子:9.9
- 作者:
P. Karschnia;Sylvia C. Kurz;P. Brastianos;Sebastian F. Winter;A. Gordon;SooAe Jones;M. Pisapia;Naema Nayyar;J. Tonn;Tracy T Batchelor;S. Plotkin;J. Dietrich - 通讯作者:
J. Dietrich
Tracy T Batchelor的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Tracy T Batchelor', 18)}}的其他基金
Harvard/Stanford GTN Program: Novel targeted therapeutics for glioblastoma
哈佛/斯坦福 GTN 项目:胶质母细胞瘤的新型靶向疗法
- 批准号:
10306226 - 财政年份:2021
- 资助金额:
$ 0.7万 - 项目类别:
Harvard/Stanford GTN Program: Novel targeted therapeutics for glioblastoma
哈佛/斯坦福 GTN 项目:胶质母细胞瘤的新型靶向疗法
- 批准号:
10491787 - 财政年份:2021
- 资助金额:
$ 0.7万 - 项目类别:
Annual Meeting of the International Primary CNS Lymphoma Collaborative Group (IPCG)
国际原发性中枢神经系统淋巴瘤协作组(IPCG)年会
- 批准号:
10391991 - 财政年份:2021
- 资助金额:
$ 0.7万 - 项目类别:
Targeting metabolic vulnerabilities in Astrocytoma, IDH-mutant, Grade 4
针对星形细胞瘤、IDH 突变、4 级的代谢脆弱性
- 批准号:
10306229 - 财政年份:2021
- 资助金额:
$ 0.7万 - 项目类别:
Targeting metabolic vulnerabilities in Astrocytoma, IDH-mutant, Grade 4
针对星形细胞瘤、IDH 突变、4 级的代谢脆弱性
- 批准号:
10491830 - 财政年份:2021
- 资助金额:
$ 0.7万 - 项目类别:
相似海外基金
Precision targeting of primary central nervous system lymphoma and its tumour microenvironment
原发性中枢神经系统淋巴瘤及其肿瘤微环境的精准靶向
- 批准号:
MR/X001415/1 - 财政年份:2023
- 资助金额:
$ 0.7万 - 项目类别:
Fellowship
Intracerebroventricular (ICV) Administration of CD19-Targeting Chimeric Antigen Receptor (CAR) T cells for Treatment of Primary Central Nervous System Lymphoma
脑室内 (ICV) 施用靶向 CD19 的嵌合抗原受体 (CAR) T 细胞治疗原发性中枢神经系统淋巴瘤
- 批准号:
10522948 - 财政年份:2022
- 资助金额:
$ 0.7万 - 项目类别:
Intracerebroventricular (ICV) Administration of CD19-Targeting Chimeric Antigen Receptor (CAR) T cells for Treatment of Primary Central Nervous System Lymphoma
脑室内 (ICV) 施用靶向 CD19 的嵌合抗原受体 (CAR) T 细胞治疗原发性中枢神经系统淋巴瘤
- 批准号:
10700973 - 财政年份:2022
- 资助金额:
$ 0.7万 - 项目类别:
Exploration of diagnostic and therapeutic biomarkers in primary central nervous system lymphoma
原发性中枢神经系统淋巴瘤诊断和治疗生物标志物的探索
- 批准号:
19K09514 - 财政年份:2019
- 资助金额:
$ 0.7万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Elucidation of novel therapeutic target using patient-derived primary central nervous system lymphoma xenograft models
使用患者来源的原发性中枢神经系统淋巴瘤异种移植模型阐明新的治疗靶点
- 批准号:
19K18398 - 财政年份:2019
- 资助金额:
$ 0.7万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Search for biomarkers of sensitivity to MTX monotherapy in primary central nervous system lymphoma
寻找原发性中枢神经系统淋巴瘤对 MTX 单药治疗敏感的生物标志物
- 批准号:
17K10880 - 财政年份:2017
- 资助金额:
$ 0.7万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of non-invasive novel diagnostic methods for primary central nervous system lymphoma using liquid biopsy for nucleic acids derived from cerebrospinal fluid
利用脑脊液核酸液体活检开发原发性中枢神经系统淋巴瘤的非侵入性新型诊断方法
- 批准号:
17K10873 - 财政年份:2017
- 资助金额:
$ 0.7万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigating Bruton's Tyrosine Kinase Dependency in Primary Central Nervous System Lymphoma
研究原发性中枢神经系统淋巴瘤中布鲁顿酪氨酸激酶依赖性
- 批准号:
9981686 - 财政年份:2017
- 资助金额:
$ 0.7万 - 项目类别:
Differentiating between Central Nervous System Lymphoma and High-grade Glioma Using Dynamic Susceptibility Contrast and Dynamic Contrast-enhanced MR Imaging with Histogram Analysis
使用动态磁敏感对比和动态对比增强 MR 成像与直方图分析区分中枢神经系统淋巴瘤和高级别胶质瘤
- 批准号:
16K20028 - 财政年份:2016
- 资助金额:
$ 0.7万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
A study of new treatment by JAK-STAT inhibition for central nervous system lymphoma
JAK-STAT抑制治疗中枢神经系统淋巴瘤新疗法的研究
- 批准号:
15K10332 - 财政年份:2015
- 资助金额:
$ 0.7万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




